116 related articles for article (PubMed ID: 16750675)
1. Patient benefits of maintenance immunotherapy.
Ghielmini M
Leuk Res; 2006 Mar; 30 Suppl 1():S22-6. PubMed ID: 16750675
[TBL] [Abstract][Full Text] [Related]
2. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
Vidal L; Gafter-Gvili A; Leibovici L; Dreyling M; Ghielmini M; Hsu Schmitz SF; Cohen A; Shpilberg O
J Natl Cancer Inst; 2009 Feb; 101(4):248-55. PubMed ID: 19211444
[TBL] [Abstract][Full Text] [Related]
3. Rituximab maintenance therapy in indolent NHL: a clinical review.
Buske C; Hiddemann W
Leuk Res; 2006 Mar; 30 Suppl 1():S11-5. PubMed ID: 16750673
[TBL] [Abstract][Full Text] [Related]
4. Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis.
Vidal L; Gafter-Gvili A; Salles G; Bousseta S; Oberman B; Rubin C; van Oers MH; Fortpied C; Ghielmini M; Pettengell R; Witzens-Harig M; Dreger P; Vitolo U; Gomes da Silva M; Evangelista A; Li H; Freedman L; Habermann TM; Shpilberg O
Eur J Cancer; 2017 May; 76():216-225. PubMed ID: 28336303
[TBL] [Abstract][Full Text] [Related]
5. Rituximab maintenance in indolent lymphoma: indications and controversies.
van Oers MH
Curr Oncol Rep; 2007 Sep; 9(5):378-83. PubMed ID: 17706166
[TBL] [Abstract][Full Text] [Related]
6. Rituximab as maintenance therapy for patients with follicular lymphoma.
Vidal L; Gafter-Gvili A; Leibovici L; Shpilberg O
Cochrane Database Syst Rev; 2009 Apr; (2):CD006552. PubMed ID: 19370640
[TBL] [Abstract][Full Text] [Related]
7. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials.
Vidal L; Gafter-Gvili A; Salles G; Dreyling MH; Ghielmini M; Hsu Schmitz SF; Pettengell R; Witzens-Harig M; Shpilberg O
J Natl Cancer Inst; 2011 Dec; 103(23):1799-806. PubMed ID: 22021664
[TBL] [Abstract][Full Text] [Related]
8. Principles of maintenance therapy.
Berinstein NL
Leuk Res; 2006 Mar; 30 Suppl 1():S3-10. PubMed ID: 16750676
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.
Boland A; Bagust A; Hockenhull J; Davis H; Chu P; Dickson R
Health Technol Assess; 2009 Sep; 13 Suppl 2():41-8. PubMed ID: 19804688
[TBL] [Abstract][Full Text] [Related]
10. Rituximab maintenance therapy in follicular lymphoma.
Forstpointner R; Dreyling M
Curr Hematol Malig Rep; 2007 Oct; 2(4):213-8. PubMed ID: 20425372
[TBL] [Abstract][Full Text] [Related]
11. Rituximab maintenance therapy for follicular lymphoma.
Haines I
Lancet; 2011 Apr; 377(9772):1151; author reply 1151-2. PubMed ID: 21459205
[No Abstract] [Full Text] [Related]
12. Prolonging remission with rituximab maintenance therapy.
Hainsworth JD
Semin Oncol; 2004 Feb; 31(1 Suppl 2):17-21. PubMed ID: 15042530
[TBL] [Abstract][Full Text] [Related]
13. Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma--a randomized phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Litchy S; Shaffer DW; Lackey VL; Grimaldi M; Greco FA
J Clin Oncol; 2005 Feb; 23(6):1088-95. PubMed ID: 15657401
[TBL] [Abstract][Full Text] [Related]
14. Should all patients with indolent lymphoma be treated with rituximab maintenance therapy? An overview of the data.
Andemariam B; Leonard JP
Clin Lymphoma Myeloma; 2006 Oct; 7 Suppl 1():S20-3. PubMed ID: 17101069
[TBL] [Abstract][Full Text] [Related]
15. Rituximab maintenance therapy: a step forward in follicular lymphoma.
van Oers MH
Haematologica; 2007 Jun; 92(6):826-33. PubMed ID: 17550856
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain.
Sabater E; López-Guillermo A; Rueda A; Salar A; Oyagüez I; Collar JM
Appl Health Econ Health Policy; 2016 Aug; 14(4):465-477. PubMed ID: 27090915
[TBL] [Abstract][Full Text] [Related]
17. Maintenance rituximab in follicular non-Hodgkin lymphoma: facts and controversies.
Nabhan C; Smith SM; Kahl BS
Leuk Lymphoma; 2012 May; 53(5):770-8. PubMed ID: 21958083
[TBL] [Abstract][Full Text] [Related]
18. Safety of rituximab maintenance therapy in follicular lymphomas.
Solal-Céligny P
Leuk Res; 2006 Mar; 30 Suppl 1():S16-21. PubMed ID: 16750674
[TBL] [Abstract][Full Text] [Related]
19. [Cost-effectiveness analysis of maintenance therapy with rituximab in patients with follicular lymphoma responding to induction therapy at the first line].
Castro Gómez AJ; López-Guillermo A; Rueda Domínguez A; Salar A; Varela Moreno C; Rubio-Terrés C
Rev Esp Salud Publica; 2012; 86(2):163-76. PubMed ID: 22991059
[TBL] [Abstract][Full Text] [Related]
20. What is the role of maintenance rituximab in follicular NHL?
Maloney DG
Oncology (Williston Park); 2008 Jan; 22(1):20-6; discussion 26, 29, 33-4. PubMed ID: 18251281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
